Literature DB >> 34336428

Coinfection of Tuberculosis in an Undiagnosed HIV, AIDS Patient Presenting With Shortness of Breath, Constitutional Symptoms and Lymphadenopathy.

Mirian V Garcia Rivera1, Angel Aponte1, War War Ko1.   

Abstract

Tuberculosis (TB) has long been known as an acquired immunodeficiency syndrome (AIDS) defining illness in human immunodeficiency virus (HIV) patients, causing reciprocal advantage for both pathogens throughout the course of the disease, not just constituting a burden for the patient, but also impacting public health globally. We report a case of a 42-year-old man who presented with shortness of breath, generalized lymphadenopathy and weight loss. Subsequently diagnosed with HIV/AIDS and generalized ganglionar TB. Initial computed tomography (CT) of the chest showed extensive mediastinal involvement with large right loculated pleural effusion, with growth of acid-fast bacilli (AFB) on culture. Biopsy of lymph nodes confirmed pathologic changes correlating with M. tuberculosis (Caseating granulomatous inflammation), ruling out the possibility of lymphoproliferative disorder. Multiple factors contribute to the immune system decline in AIDS patients, moreover the rapid depletion of Tuberculosis antigen-specific CD4+ T before generalized CD4+T cells. Early assessment for the presence of co-infection and guidance of targeted therapy is critical for management and an important factor in the expected recovery of such patients. Therefore, understanding the pathogenesis of the co-infection, diagnostic approach, possible complications, and the action of concurrent therapy highly active antiretroviral therapy (HAART)/anti-Tuberculosis treatment as well as drug cytotoxicity is paramount.
Copyright © 2021, Garcia Rivera et al.

Entities:  

Keywords:  aids; antiretroviral; coinfection; hiv; infections; opportunistic; therapy; tuberculosis

Year:  2021        PMID: 34336428      PMCID: PMC8312766          DOI: 10.7759/cureus.15925

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

Review 1.  Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection.

Authors:  R M G J Houben; A C Crampin; R Ndhlovu; P Sonnenberg; P Godfrey-Faussett; W H Haas; G Engelmann; C J Lombard; D Wilkinson; J Bruchfeld; S Lockman; J Tappero; J R Glynn
Journal:  Int J Tuberc Lung Dis       Date:  2011-01       Impact factor: 2.373

2.  The peculiarities of immunological indicators in hiv-infected persons with tuberculosis

Authors:  Vasyl D Moskaliuk; Tetiana R Kolotylo; Khrystyna I Pudiak; Ivanna V Rudan; Oksana I Goliar; Iryna V Balanyk
Journal:  Wiad Lek       Date:  2019-10-31

3.  Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.

Authors:  Kathrin Zürcher; Marie Ballif; Lukas Fenner; Sonia Borrell; Peter M Keller; Joachim Gnokoro; Olivier Marcy; Marcel Yotebieng; Lameck Diero; E Jane Carter; Neesha Rockwood; Robert J Wilkinson; Helen Cox; Nicholas Ezati; Alash'le G Abimiku; Jimena Collantes; Anchalee Avihingsanon; Kamon Kawkitinarong; Miriam Reinhard; Rico Hömke; Robin Huebner; Sebastien Gagneux; Erik C Böttger; Matthias Egger
Journal:  Lancet Infect Dis       Date:  2019-02-08       Impact factor: 25.071

Review 4.  Tuberculosis Diagnostics: State of the Art and Future Directions.

Authors:  Madhukar Pai; Mark P Nicol; Catharina C Boehme
Journal:  Microbiol Spectr       Date:  2016-10

5.  Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children.

Authors:  David M Lewinsohn; Michael K Leonard; Philip A LoBue; David L Cohn; Charles L Daley; Ed Desmond; Joseph Keane; Deborah A Lewinsohn; Ann M Loeffler; Gerald H Mazurek; Richard J O'Brien; Madhukar Pai; Luca Richeldi; Max Salfinger; Thomas M Shinnick; Timothy R Sterling; David M Warshauer; Gail L Woods
Journal:  Clin Infect Dis       Date:  2016-12-08       Impact factor: 9.079

6.  How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners.

Authors:  Pam Sonnenberg; Judith R Glynn; Katherine Fielding; Jill Murray; Peter Godfrey-Faussett; Stuart Shearer
Journal:  J Infect Dis       Date:  2004-12-13       Impact factor: 5.226

7.  Detection of pulmonary tuberculosis in patients with a normal chest radiograph.

Authors:  D D Marciniuk; B D McNab; W T Martin; V H Hoeppner
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

Review 8.  Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: focus on drug-drug interactions with rifamycins.

Authors:  Mario Regazzi; Anna Cristina Carvalho; Paola Villani; Alberto Matteelli
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

Review 9.  The Effect of Early Initiation of Antiretroviral Therapy in TB/HIV-Coinfected Patients: A Systematic Review and Meta-Analysis.

Authors:  Solomon M Abay; Kebede Deribe; Ayalu A Reda; Sibhatu Biadgilign; Daniel Datiko; Tigist Assefa; Maja Todd; Amare Deribew
Journal:  J Int Assoc Provid AIDS Care       Date:  2015-08-19

10.  Sputum Smear and Culture-negative Tuberculosis with Associated Pleural Effusion: A Diagnostic Challenge.

Authors:  Muhammad U Asghar; Sanwal S Mehta; Hira A Cheema; Ravikaran Patti; William Pascal
Journal:  Cureus       Date:  2018-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.